Forte Biosciences, Inc. Gains 78.33%

Thu, Jul 09, 2026 at 07:44 PM

Forte Biosciences, Inc. (FBRX:NASDAQ) rocketted at $36.7, a gain of 78.3%. On Thu, Jul 09, 2026, FBRX:NASDAQ touched a New 2-Week High of $36.7. The stock appeared on our News Catalysts scanner on Thu, Jul 09, 2026 at 03:36 PM in the 'MISCELLANEOUS' category. From Thu, Jun 25, 2026, the stock recorded 55.56% Up Days and 60.00% Green Days

About Forte Biosciences, Inc. (FBRX:NASDAQ)

Forte Biosciences Inc is a clinical-stage biopharmaceutical company, focused on dermatology. The company is developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases.

Top 10 Gainers:

Julong Holding Limited (JLHL:NASDAQ), 317.97%
Virax Biolabs Group Limited (VRAX:NASDAQ), 100%
Forte Biosciences, Inc. (FBRX:NASDAQ), 78.33%
First Tracks Biotherapeutics Inc. (TRAX:NASDAQ), 55.99%
Wrap Technologies, Inc. (WRAP:NASDAQ), 48.43%
Trident Digital Tech Holdings Ltd (TDTH:NASDAQ), 41.53%
Republic Power Group Ltd (RPGL:NASDAQ), 33.15%
rYojbaba Co. Ltd. (RYOJ:NASDAQ), 31.53%
Sadot Group Inc. (SDOT:NASDAQ), 31.51%
UTime Limited (FXHO:NASDAQ), 28.79%